Evidence map›Paper›PMID 28492485›Full record

ReviewMolecules (Basel, Switzerland)2017

Sulfated Alginates as Heparin Analogues: A Review of Chemical and Functional Properties.

Øystein Arlov, Gudmund Skjåk-Bræk

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Anti-inflammatory hydrogel dressings and skin wound healing.Clinical and translational medicine · 2022
    Review
  10. Article
  11. Hydrogels in Spinal Cord Injury Repair: A Review.Frontiers in bioengineering and biotechnology · 2022
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Øystein ArlovDepartment of Biotechnology and Nanomedicine, SINTEF Materials and Chemistry, Richard Birkelands vei 3B, 7034 Trondheim, Norway. oystein.arlov@sintef.no.
Gudmund Skjåk-BrækDepartment of Biotechnology, Norwegian University of Science and Technology, Sem Sælands vei 6/8, 7034 Trondheim, Norway. gudmund.skjak.brak@ntnu.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heparin is widely recognized for its potent anticoagulating effects, but has an additional wide range of biological properties due to its high negative charge and heterogeneous molecular structure. This heterogeneity has been one of the factors in motivating the exploration of functional analogues with a more predictable modification pattern and monosaccharide sequence, that can aid in elucidating structure-function relationships and further be structurally customized to fine-tune physical and biological properties toward novel therapeutic applications and biomaterials. Alginates have been of great interest in biomedicine due to their inherent biocompatibility, gentle gelling conditions, and structural versatility from chemo-enzymatic engineering, but display limited interactions with cells and biomolecules that are characteristic of heparin and the other glycosaminoglycans (GAGs) of the extracellular environment. Here, we review the chemistry and physical and biological properties of sulfated alginates as structural and functional heparin analogues, and discuss how they may be utilized in applications where the use of heparin and other sulfated GAGs is challenging and limited.

Indexed as

AlginatesAnticoagulantsBlood CoagulationCarbohydrate SequenceComplement System ProteinsGene Expression RegulationGlucuronic AcidGlycosaminoglycansHeparinHexuronic AcidsHumansNF-kappa Bp38 Mitogen-Activated Protein KinasesSulfatesTranscription, GeneticAlginatesAnticoagulantsComplement System ProteinsGlucuronic AcidGlycosaminoglycansHeparinHexuronic AcidsNF-kappa Bp38 Mitogen-Activated Protein KinasesSulfatesalginatebiomaterialsheparinsulfated alginate

Identifiers

PMID28492485
PMCPMC6154561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.